Impact of a Focal Muscle Vibration Protocol in Front of the the Anterior Tibial Muscle in the Subacute Post-stroke Period on Motor Recovery in Hemiplegic Patients.
VIBRATAC
2 other identifiers
interventional
38
1 country
2
Brief Summary
In about 40 percent of cases, after a stroke, neuromotor impairment leads to activity limitations and the development of chronic functional disorders, which have a significant impact on patient autonomy. In the early subacute phase, motor deficit in foot lifters is one of the factors limiting standing posture and ambulation, which is ultimately difficult to rehabilitate due to the lack of available techniques for obtaining early onset of useful active voluntary contraction. The use of muscular focal vibration therapy, applied to relaxed muscle, may be of interest due to the portability and availability of the system and the neuromotor benefits demonstrated in healthy subjects and in acute and chronic post-stroke patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable stroke
Started May 2021
Typical duration for not_applicable stroke
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 28, 2021
CompletedFirst Posted
Study publicly available on registry
February 3, 2021
CompletedStudy Start
First participant enrolled
May 14, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 29, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2023
CompletedDecember 27, 2023
December 1, 2023
2.4 years
January 28, 2021
December 26, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
score of Fugl Meyer Assessment (lower limbs)
score from 0 to 34 Stroke-specific performance-based disability index that quantitatively assesses analytical motor skills in the lower limb.
day 30
Secondary Outcomes (6)
score of Fugl Meyer Assessment (lower limbs)
day 0, day 15, day 30 and month 2
score of Medical Research Concil
day 0, day 15, day 30 and month 2
assess functional walking ability
day 0, day 15, day 30 and month 2
score of postural assessment scale for stroke
day 0, day 15, day 30 and month 2
analysis of static equilibrium
day 0, day 15, day 30 and month 2
- +1 more secondary outcomes
Study Arms (2)
vibration program
EXPERIMENTALa 4-week program of muscular focal vibrations, at the rate of 5 sessions of 30 minutes per week, in addition to conventional rehabilitation. The program will apply a frequency of 100 Hz, with an amplitude of 1 mm
sham program
SHAM COMPARATORa 4-week program of muscular focal vibrations, at the rate of 5 sessions of 30 minutes per week, in addition to conventional rehabilitation.
Interventions
assessment of motor skills : measurement of the intensity of reflexes, as well as an assessment of voluntary movements and motor coordination Score from 0 to 34
evaluation of muscular strength score from 0 to 5
Assess functional walking and aerobic abilities
measures the time it takes to get up from a chair, walk 10 feet, turn around, return to the seat and sit down
score from 0 to 36 measures the patient's ability to maintain stable postures and balance in changes of position
analysis of static equilibrium parameters and positional measurement of the center of gravity on the Winposturo platform
a 4-week program of muscular focal vibrations, at the rate of 5 sessions of 30 minutes per week, in addition to conventional rehabilitation. The program will apply a frequency of 100 Hz, with an amplitude of 1 mm
a 4-week program of muscular focal vibrations, at the rate of 5 sessions of 30 minutes per week, in addition to conventional rehabilitation.
Eligibility Criteria
You may qualify if:
- Having had a stroke (with or without previous stroke) and being in the early subacute phase (between 14 days and 3 months of stroke).
- Responsible for a motor deficit in the right or left lower limb.
- No neurological history other than stroke.
You may not qualify if:
- Multifocal stroke
- Patient having received a botulinum toxin injection to the lower limb to be vibrated
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Centre Hospitalier Universitaire de Saint-Etienne
Saint-Etienne, 42055, France
Le Clos Champirol - Service de Médecine Physique et de Réadaptation
Saint-Priest-en-Jarez, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bruno FERNANDEZ, MD
CHU SAINT-ETIENNE
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 28, 2021
First Posted
February 3, 2021
Study Start
May 14, 2021
Primary Completion
September 29, 2023
Study Completion
December 15, 2023
Last Updated
December 27, 2023
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share